Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
TEL AVIV STOCK EXCHANGE
13:44:58 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 10,960.00 ILa | -0.36% |
|
-0.63% | +8.62% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-04 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.37B 12,751B 36.5B 34.3B 31.35B 58.61B 4,003B 58.83B 405B 157B 2,051B 159B 156B 6,614B | P/E 2026 * |
48.8x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 54.27B 16,333B 46.76B 43.94B 40.16B 75.07B 5,127B 75.36B 519B 201B 2,627B 204B 199B 8,472B | EV / Sales 2026 * |
3.27x | EV / Sales 2027 * | 2.95x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | -0.36% | ||
| 1 week | -0.63% | ||
| Current month | +2.33% | ||
| 1 month | +5.08% | ||
| 3 months | +9.98% | ||
| 6 months | +11.16% | ||
| Current year | +8.62% |
| 1 week | 10,660 |  | 11,530 |
| 1 month | 10,400 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -0.63% | - | - | 42.37B | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.88% | +1.09% | +28.65% | +52.33% | 408.71B | |
| Weighted average by Cap. | -0.95% | +0.55% | +37.63% | +67.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.59B 4,993B 14.29B 13.43B 12.28B 22.95B 1,567B 23.04B 159B 61.53B 803B 62.3B 60.93B 2,590B | 17.3B 5,208B 14.91B 14.01B 12.81B 23.94B 1,635B 24.03B 166B 64.18B 838B 64.98B 63.56B 2,701B |
| Net income | 1.44B 434B 1.24B 1.17B 1.07B 1.99B 136B 2B 13.78B 5.34B 69.77B 5.41B 5.29B 225B | 2.69B 809B 2.32B 2.18B 1.99B 3.72B 254B 3.73B 25.71B 9.97B 130B 10.09B 9.87B 420B |
| Net Debt | 11.9B 3,582B 10.25B 9.64B 8.81B 16.46B 1,124B 16.53B 114B 44.14B 576B 44.69B 43.71B 1,858B | 8.65B 2,604B 7.45B 7B 6.4B 11.97B 817B 12.01B 82.75B 32.09B 419B 32.49B 31.78B 1,351B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ILA 10,960.00 | -0.36% | 473,654 |
| 03/09/26 | ILA 11,000.00 | -0.09% | 983,311 |
| 02/09/26 | ILA 11,010.00 | -0.09% | 1,791,302 |
| 01/09/26 | ILA 11,020.00 | +2.89% | 1,141,409 |
| 31/08/26 | ILA 10,710.00 | -2.90% | 905,060 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
